Lukas Baumhove

Lukas Baumhove is a cardiovascular researcher at the University of Groningen, specializing in heart failure mechanisms with emphasis on inflammatory pathways and biomarker discovery. His work spans both chronic and acute heart failure subtypes, focusing on immunological drivers and sex-specific risk factors.

His primary research interests center on inflammatory processes in heart failure, particularly the role of interleukin-17 family cytokines and extracellular matrix proteins. Current investigations include phospholamban-related cardiomyopathy (DECIPHER-PLN cohort), sex differences in heart failure development (PREVEND study), and diagnostic differentiation of cardiac amyloidosis subtypes. His fingerprint analysis reveals strong engagement with heart failure (100%), inflammation (52%), and interleukin-17 pathways (38%).

Article analysis shows consistent focus on translational cardiology, with recent work bridging basic immunology and clinical cardiology. Key trends include biomarker validation for heart failure subtypes, sex-specific pathophysiological mechanisms, and inflammatory pathway modulation as potential therapeutic targets. Publications appear in high-impact journals including European Heart Journal and Cardiovascular Research.

Baumhove actively collaborates with major cardiology research groups across Europe, particularly within the University Medical Center Groningen network. His thesis research (2025) established foundational work on inflammatory mechanisms across the heart failure spectrum, while ongoing projects like DECIPHER-PLN explore genetic modifiers in rare cardiomyopathies. Current research aligns with UN Sustainable Development Goals related to good health and well-being through cardiovascular disease prevention and precision medicine approaches.